CTLA4 and type 1 diabetes mellitus: Subsequently we assessed their impacts on glycemic traits based on an oral glucose tolerance test (OGTT) in healthy individuals and residual C-peptide levels in newly diagnosed T1D patients, and their influences on quantitative changes of CTLA-4 expression in different T cell subsets and autoantibody positivity during T1D development.